ANA773 Resumes Race Against Hepatitis C

July 10th, 2008 by admin

By reaction the dosing schedule in half, Anadys Pharmaceuticals returns to their enquiry of ANA773, a Toll-Like Receptor-7 character prodrug. Approaching the Hepatitis C virus differently from most another contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load…

Posted in Hepatology |

Related posts

Comments are closed.